Neisseria meningitidis capsular polysaccharides (serogroups A, C, W-135, and Y) (MenACWY polysaccharides)

Neisseria meningitidis capsular polysaccharides are complex carbohydrate polymers that form the outermost layer of the bacterium, serving as a critical virulence factor (WHO, 2023). These polysaccharides protect the pathogen from the host's immune system by inhibiting phagocytosis and resisting complement-mediated lysis (CDC, 2022). There are several distinct serogroups based on the chemical composition of the capsule, with A, C, W-135, and Y being major causes of invasive meningococcal disease worldwide. In medical practice, these polysaccharides are used as the primary antigens in quadrivalent meningococcal vaccines (MenACWY). When administered, often conjugated to a carrier protein to enhance immunogenicity, they stimulate the production of protective antibodies that recognize and neutralize the bacteria. This immune response prevents life-threatening conditions such as meningitis and septicemia (StatPearls, 2023). The chemical structure of these polysaccharides varies; for example, serogroup A consists of N-acetyl-D-mannosamine-1-phosphate, while serogroup C is composed of N-acetylneuraminic acid (PubChem, 2024).

Other names

Meningococcal capsular polysaccharidesGroup A, C, W, and Y polysaccharidesN. meningitidis capsular antigensQuadrivalent meningococcal polysaccharidesMenACWY antigensSerogroup A, C, W, and Y polysaccharides

These polysaccharides serve as the primary antigens in vaccines to induce the production of serogroup-specific capsular antibodies. These antibodies facilitate complement-mediated bactericidal killing and opsonophagocytosis of Neisseria meningitidis, providing active immunity against invasive disease (StatPearls, 2023; CDC, 2022).